Purpose
to research drug options for intermittent presumptive treatment for malaria in infants in an area with high resistance to sulfadoxine/pyrimethamine
Grantee
Division
Global Health
Date
MARCH 2004
Region served
AFRICA
Committed amount
$2,006,798
Grant topic
Malaria
Duration (months)
54
Grantee location
London, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.